SPA
VMD icon

Sherbrooke Park Advisers’s Viemed Healthcare VMD Stock Holding History

Sherbrooke Park Advisers’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-31,131
Closed -$204K – 1293
2024
Q2 		$204K Buy
+31,131
New +$235K 0.04% 765

Other funds holding VMD

Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $201M AUM 9.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KLP
Kent Lake PR Anasco, Puerto Rico $198M AUM 5.21% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Sherbrooke Park Advisers's VMD Position: Q3 2024 in Review

Sherbrooke Park Advisers sold out of Viemed Healthcare (VMD) in Q3 2024, closing a stake of 31,131 shares — an estimated $204K sold.

Sherbrooke Park Advisers first reported a position in VMD in Q2 2024 and held it in 1 quarter. The position peaked at $204K in Q2 2024. 121 funds tracked by Wall St. Rank hold VMD as of Q3 2024.

  • Sherbrooke Park Advisers reported no remaining Viemed Healthcare position as of Q3 2024 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 31,131 Viemed Healthcare shares in Q3 2024, an estimated $204K.
  • Sherbrooke Park Advisers first reported a position in Viemed Healthcare in Q2 2024 and held it in 1 quarter.
  • Sherbrooke Park Advisers's Viemed Healthcare position peaked at $204K in Q2 2024.
  • 121 funds tracked by Wall St. Rank held Viemed Healthcare as of Q3 2024.

Based on Sherbrooke Park Advisers's 13F filing for Q3 2024, filed 14 Nov 2024.